Wed, 02 Oct 2024
Seminar Series
Email
Print

Dr. Renata Oballa

Chinook Therapeutics

Discovery of CHK-336: A Liver-Targeted, Small Molecule Lactate Dehydrogenase Inhibitor for Hyperoxaluria Treatment

Wednesday, October 02, 2024
SSB 7172 @ 3:30 p.m.

Host: Dr. Robert Young